The Effects of MAP and EtCO2 on Venous Sinus Pressures

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 20, 2019

Primary Completion Date

September 25, 2019

Study Completion Date

September 25, 2019

Conditions
Idiopathic Intracranial Hypertension
Interventions
PROCEDURE

Venous Sinus Stenting

Venous sinus stenting is performed under general anesthesia. Patients are loaded with aspirin and clopidogrel before the procedure. After induction, the right femoral vein is accessed and an 8 F sheath is placed. Intravenous heparin is administered. A 0.070-0.088 guide catheter is navigated into the ipsilateral jugular vein near the jugular bulb. Pre-stenting manometry is performed in every patient. To do so, a Renegade Hi-Flo microcatheter is navigated into the superior sagittal sinus and then used to measure ipsilateral venous pressures across the site of outflow obstruction (this will be the time point where the study intervention will be performed).

OTHER

Adjustment to end-tidal carbon dioxide concentrations ( 38-40 mmHg range)

End-tidal carbon dioxide concentrations will be adjusted to fall in the End-tidal carbon dioxide concentrations will be adjusted to fall in the 38-40 mmHg range

OTHER

Adjustment to Mean Arterial Pressure (100-110 mmHg range)

Mean arterial pressure will be adjusted to fall in the 100-110 mmHg range

OTHER

Adjustment to Mean Arterial Pressure (60-80 mmHg range)

Mean arterial pressure will be adjusted to fall in the 60-80 mmHg range

OTHER

Adjustment to end-tidal carbon dioxide concentrations (24-26 mmHg range)

End-tidal carbon dioxide concentrations will be adjusted to fall in the 24-26 mmHg range

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03867461 - The Effects of MAP and EtCO2 on Venous Sinus Pressures | Biotech Hunter | Biotech Hunter